cagrilintide clinical trials results New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) Novo Nordisk's Cagrilintide shows promising
Pay in 4 interest-free payments of $5.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28













:max_bytes(150000):strip_icc()/GettyImages-2126120280-94c8334d07474c6883f6bb568b95693f.jpg)













